Aug 1 (Reuters) - Arrowhead Pharmaceuticals Inc ( ARWR )
:
* ARROWHEAD SUBSIDIARY VISIRNA SELLS RIGHTS TO
HYPERTRIGLYCERIDEMIA CANDIDATE PLOZASIRAN IN GREATER CHINA TO
SANOFI
* ARROWHEAD PHARMACEUTICALS INC ( ARWR ) - SANOFI TO PAY $130 MILLION
UPFRONT, $265 MILLION IN MILESTONES
* ARROWHEAD PHARMACEUTICALS INC ( ARWR ) - SANOFI RECEIVES EXCLUSIVE
LICENSE FOR PLOZASIRAN IN CHINA
Source text:
Further company coverage: